Getting Ahead of the Reimbursement Curve: How Will Your Immune Biologic Brand Fare?

Thanks to healthcare reform, prodding by the federal government and new benefit designs, we’re seeing substantial changes in store with the market.With the rollout of new Medicare plans for 2011, we’re able to get a view of the changing design of Part D plans and how it could affect buying behavior.